Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Burning Rock Biotech Ltd ADR (NQ: BNR ) 4.900 -0.400 (-7.55%) Streaming Delayed Price Updated: 2:28 PM EDT, Sep 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Burning Rock Biotech Ltd ADR < Previous 1 2 3 4 Next > The Daily Biotech Pulse: Pfizer Strikes $5.29B COVID Pill Supply Deal With US, Roche's Spark Therapeutics Reports Positive Gene Therapy Readout, EDAP Earnings November 18, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus Roche's Spark Subsidiary Reports Positive Phase 1/2 Data For Hemophilia... Via Benzinga Burning Rock Biotech Limited (BNR) Q3 2021 Earnings Call Transcript November 17, 2021 BNR earnings call for the period ending September 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial Recap: Burning Rock Biotech Q3 Earnings November 16, 2021 Burning Rock Biotech (NASDAQ:BNR) reported its Q3 earnings results on Tuesday, November 16, 2021 at 08:00 AM. Here's what investors need to know about the announcement... Via Benzinga Earnings Scheduled For November 16, 2021 November 16, 2021 Companies Reporting Before The Bell • Ozon Holdings (NASDAQ:OZON) is expected to report quarterly loss at $0.90 per share on revenue of $602.00 million. • Sea (... Via Benzinga The Daily Biotech Pulse: Pfizer, Bristol-Myers Squibb Earnings, Amgen Goes Shopping, GlaxoSmithKline-Vir's COVID-19 Antibody Treatment Supply Deal July 28, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs July 27) Bio-Rad Laboratories, Inc... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: Takeda Suspends Studies On Safety Scare, Acer's Sleep Disorder Drug Filing Accepted For Review, Voyager's Licensing Options Deal October 06, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 5) Bicycle Therapeutics plc (... Via Benzinga The Daily Biotech Pulse: J&J Files For Booster Dose Authorization, Gemini Restructures, Strata Skin CFO Departs, Kaleido Reports Positive Readout October 05, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Oct. 4) Avadel Pharmaceuticals plc (... Via Benzinga The Daily Biotech Pulse: Merck Confirms Acceleron Purchase, Regeneron Touts COVID-19 Antibody Cocktail Data, Takeda In-Licenses Huntington's Disease Drug September 30, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Sept. 29) Acceleron Pharma Inc. (... Via Benzinga Exposures COVID-19 The Daily Biotech Pulse: AbbVie's Migraine Drug OK'd By FDA, Amicus Spins Off Gene Therapy Business, Geovax In-Licenses Cancer Drug September 29, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Click here for accessing Benzinga's FDA Calendar Scaling The Peaks (Biotech Stocks... Via Benzinga Exposures Product Safety 12 Health Care Stocks Moving In Friday's After-Market Session September 24, 2021 Gainers eFFECTOR Therapeutics (NASDAQ: Via Benzinga The Daily Biotech Pulse: Merck Releases Twin Dose Of Positive Tidings, Astellas Voluntarily Pauses Gene Therapy Study, Ascendis Offering September 01, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours. Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 31) AC Immune SA (NASDAQ: ACIU... Via Benzinga Burning Rock Biotech Limited (BNR) Q2 2021 Earnings Call Transcript August 31, 2021 BNR earnings call for the period ending June 30, 2021. Via The Motley Fool Topics Earnings Exposures Financial The Week Ahead In Biotech (Aug. 29- Sept. 4): Merck's Keytruda Regulatory Decision, Stray Earnings On Tap In a Light Week August 29, 2021 Biopharma stocks had a strong start to the week amid optimism generated by full approval accorded to the mRNA vaccine developed by Pfizer, Inc. (NYSE: PFE) and BioNTech SE (... Via Benzinga The Daily Biotech Pulse: VectivBio In M&A Mix, Sonnet Biotherapeutics Advances Candidate To Clinics, CEO Transitions At Galapagos, Talis Biomedical August 31, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 26) Agenus Inc. (NASDAQ: AGEN)... Via Benzinga Burning Rock Biotech Limited (BNR) Q1 2021 Earnings Call Transcript May 26, 2021 BNR earnings call for the period ending March 31, 2021. Via The Motley Fool Topics Earnings Exposures Financial Earnings Scheduled For May 25, 2021 May 25, 2021 Companies Reporting Before The Bell • Elbit Systems (NASDAQ:ESLT) is likely to report quarterly earnings at $1.40 per share on revenue of $1.10 billion. • Burning... Via Benzinga The Daily Biotech Pulse: Sanofi Buys Translate Bio In $3.2B Deal, Lilly's Q2 Earnings Disappoint, Bausch To Spin Off Medical Aesthetics Business August 03, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs Aug. 2) Absci, CORP (NASDAQ: ABSI) (... Via Benzinga 74 Biggest Movers From Yesterday July 27, 2021 Gainers Bit Digital, Inc. (NASDAQ: BTBT) shares jumped 109.7% to close at $8.87 on Monday after the company announced it entered into a second strategic co-mining agreement with... Via Benzinga The Week Ahead In Biotech (May 23-29): Eton, Lantheus FDA Decisions, Adcom Test For Provention, Chiasma Data Presentation May 23, 2021 Biotech stocks advanced in the week ended May 21, as risk aversion forced traders to buy into defensives. As earnings news flow tapered, stocks took cues from clinical readouts.... Via Benzinga Exposures Product Safety Benzinga's Top Ratings Upgrades, Downgrades For July 14, 2021 July 14, 2021 Upgrades CL King upgraded the previous rating for Compass Minerals International Inc (NYSE: Via Benzinga Week In Review: LianBio Acquires Two IBD Candidates In $218 Million Deal May 22, 2021 LianBio, a Princeton-Shanghai company, in-licensed Greater China rights for two inflammatory bowel disease candidates from Landos Biopharma. The $218 million deal includes $18 million upfront and $200... Via Talk Markets 40 Stocks Moving In Wednesday's Mid-Day Session May 12, 2021 Gainers Ra Medical Systems, Inc. (NASDAQ: RMED) shares jumped 76% to $5.84 after the company reported better-than-expected Q1 results. Lucira Health, Inc. (NASDAQ: LHDX) gained... Via Benzinga The Daily Biotech Pulse: Pfizer In Vaccine Supply Talks With India, Provention In Focus Ahead Of Briefing Doc, NeuroRx To List Via SPAC Deal May 25, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs May 24) Bristol-Myers Squibb Company... Via Benzinga 62 Biggest Movers From Yesterday May 13, 2021 Gainers Curis, Inc. (NASDAQ: CRIS) shares surged 65.5% to settle at $16.27 on Wednesday in reaction to updated data from its ongoing open-label, single-arm, Phase 1/2 study of CA... Via Benzinga The Daily Biotech Pulse: Leadership Transition At Amarin, Vaccine Setback For J&J, FDA Nod For Label Expansion of Roche's Asthma Drug April 13, 2021 Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs April 12) 180 Life Sciences Corp. (... Via Benzinga Exposures Product Safety < Previous 1 2 3 4 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.